Thiolation of peptides for radionuclide-based radiodetection and

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 111, 424 165, 530300, A61K 5100, A61M 3614

Patent

active

057469962

ABSTRACT:
A method of radiolabeling a peptide, e.g., somatostatin or an analogue thereof or vasoactive intestinal peptide, with a radioisotope of technetium or rhenium, comprises the steps of: (a) reacting the peptide with an acetyl-protected t-thiol-containing, amine-reactive bifunctional chelating agent; (b) deprotecting the acetyl-t-thiol group to generate a free t-thiol group; and either (c) admixing the peptide-t-thiol-containing conjugate with a stannous salt; and (d) reacting the mixture of step (c) with pertechnetate or perrhenate, or (c') adding reduced pertechnetate or perrhenate to said peptide-t-thiol-containing conjugate, thereby forming a radiolabeled peptide. Kits for effecting the radiolabeling method, and methods of tumor detection/imaging or therapy are provided.

REFERENCES:
patent: 4323546 (1982-04-01), Crockford et al.
patent: 4424200 (1984-01-01), Crockford et al.
patent: 4883862 (1989-11-01), Chervu et al.
patent: 4932412 (1990-06-01), Goldenberg
patent: 5026913 (1991-06-01), McBride et al.
patent: 5061641 (1991-10-01), Shochat et al.
patent: 5080884 (1992-01-01), McBride et al.
patent: 5082930 (1992-01-01), Nicolotti et al.
patent: 5095111 (1992-03-01), Lever et al.
patent: 5102990 (1992-04-01), Rhodes
patent: 5128119 (1992-07-01), Griffiths
patent: 5180816 (1993-01-01), Dean
patent: 5196515 (1993-03-01), Lever et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5242679 (1993-09-01), Fritzberg et al.
patent: 5245018 (1993-09-01), Kondo et al.
patent: 5310536 (1994-05-01), Srinivasan
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5395946 (1995-03-01), Goedemans et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
Greenfield, et al. "Thiol-Containing Cross-Linking Agent with Enhanced Steric Hindrance," Bioconjugate Chem. 1, 400-10 (1990).
Khaw et al.--J. Nucl. Med. 23:1011-19 (1982), "Technetium-99m Labeling of Antibodies to Cardiac Myosin Fab and to Human Fibrinogen".
Khaw et al.--Science, 209:295-97 (1980), "Myocardial Infarct Imaging of Antibodies to Canine Cardiac Myosin with Indium-111-Diethylenetriamine Pentaacetic Acid".
Krejcarek, et al.--Biochem. Byophys. Res. Commun., 77:581-85 (1977), "Covalent Attachment of Chelating Groups to Macromolecules".
Childs, et al.--J. Nucl. Med., 26:293 (1985), "Optimum Conditions for Labeling of DTPA Coupled Antibodies with Technetium-99m".
Fritzberg, et al.--J. Nucl. Med., 27:957, (1986), "Radiopharmaceutical Chemistry v. Antibodies".
Baidoo, et al.--Cancer Research (Supp.) 50:799s-803s, (1990), "Tc Labeling of Proteins: Initial Evaluation of a Novel Diaminedithiol Bifunctional Chelating Agent".
Wong--Chemistry of Protein Conguation and Cross-Linking, CRC Press, Inc., Boca Raton, Florida, pp. 17-23 (1991), "Reactive Groups of Proteins and Their Modifying Agents".
McCall, et al.--Bioconjugate Chem., 1:222-26 (1990), "Simplified Method for Conjugating Macrocyclic Bifunctional Chelating Agents to Antibodies via 2-Iminothiolane".
Golf, et al.--Bioconjugate Chem., 1:381-86 (1990), Substituted 2-Iminothiolanes: Reagents for the Preparation of Disulfide Cross-Linked Conjugates with Increased Stability.
Parker, Sybil P., ed., McGraw-Hill Dictionary of Chemical Terms, p. 211 (1984).
Virgolini, et al.--Cancer Res., 54: 690-700 (1994), "Cross-Competition between Vasoactive Intestinal Peptide and Somatostatin for Binding to Tumor Cell Membrane Receptors".
Virgolini, et al.--J. Nucl. Med., 35(5): 97P (1994), "Vasoactive Intestinal Peptide (VIP) Receptor Imaging in the Localization of Intestinal Adenocarcinomas and Endocrine Tumors".(abstract).
Maini, et al.--Nucl. Med. Commun., 14:962-968 (1993), "Somatostatin Receptor Imaging in Small Cell Lung Cancer Using .sup.111 In-DTPA-octreotide: a Preliminary Study".
Lamberts, et al.--New Eng. J. of Med., 323(18): 1246-1249 (1990), "Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thiolation of peptides for radionuclide-based radiodetection and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiolation of peptides for radionuclide-based radiodetection and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiolation of peptides for radionuclide-based radiodetection and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-50878

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.